| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/26/2001 | CA2387185A1 Self-cleaving rna sequences and their use for the control of protein synthesis |
| 04/26/2001 | CA2387041A1 Human sit4 associated proteins like (sapl) proteins and encoding genes; uses thereof |
| 04/26/2001 | CA2386922A1 Novel polypeptides and polynucleotides encoding same |
| 04/26/2001 | CA2386596A1 Novel germinal center kinase cell cycle proteins, compositions and methods of use |
| 04/26/2001 | CA2386415A1 New lymphocytes, a process for preparing the same and their use in therapeutics |
| 04/26/2001 | CA2386401A1 Preparation of cellular components that are substantially free of chromosomal dna |
| 04/26/2001 | CA2386270A1 Rna interference pathway genes as tools for targeted genetic interference |
| 04/26/2001 | CA2384841A1 Death domain-containing receptor polynucleotides, polypeptides, and antibodies |
| 04/26/2001 | CA2384573A1 Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis |
| 04/26/2001 | CA2384264A1 Protein tyrosine kinase receptor polynucleotides, polypeptides, and antibodies |
| 04/26/2001 | CA2324385A1 Method for increasing the production of physiologically active substances by cultured cells |
| 04/25/2001 | WO2003054202A1 Generation of human neural crest stem cell line and its utilization in human transplantation |
| 04/25/2001 | EP1094113A1 Regeneration |
| 04/25/2001 | EP1094109A2 Human G protein-coupled receptor, PFI-010 |
| 04/25/2001 | EP1094081A1 Fused protein with direct bond of il-6-receptor to il-6 |
| 04/25/2001 | EP1094080A2 Anti-dnase-gamma antibody, and production and use thereof |
| 04/25/2001 | EP1094076A1 Human G-protein coupled receptor |
| 04/25/2001 | EP1094075A1 Human G-protein coupled receptor |
| 04/25/2001 | EP1094070A2 Lawsonia intracellularis proteins, and related methods and materials |
| 04/25/2001 | EP1093820A2 Oral immunology using plant product containing hepatitis surface antigen |
| 04/25/2001 | EP1093526A2 Characterisation of gene function using double stranded rna inhibition |
| 04/25/2001 | EP1093524A1 Recombinant herpes viruses for preparing recombinant adeno-associated viruses |
| 04/25/2001 | EP1093521A2 Human transferases |
| 04/25/2001 | EP1093520A1 Hmp-p kinase and tmp-ppase from arabidopsis thaliana and their use in herbicide screening |
| 04/25/2001 | EP1093519A2 Amphiphilic peptides derived from the cytoplasmic tail of viral envelope proteins |
| 04/25/2001 | EP1093516A2 Mammalian genes; dendritic cell prostaglandin-like transporter (dc-pgt), hdtea84, hsljd37r and rankl, hcc5 chemokine, deubiquitinating 11 and 12 (dub11, dub12), md-1, md2 and cyclin e2, related reagents and methods |
| 04/25/2001 | EP1093515A1 Electrofusion chamber |
| 04/25/2001 | EP1093513A1 Bioreactor and cell culturing processes using the bioreactor |
| 04/25/2001 | EP1093457A1 Cytokine receptor common gamma chain like |
| 04/25/2001 | EP1093381A1 Antigenic peptides derived from telomerase |
| 04/25/2001 | EP1093378A1 Compositions and methods for prevention and treatment of uncontrolled formation of intravascular fibrin clots |
| 04/25/2001 | EP1093333A1 Receptor-like protein kinase, rkn, and methods of use for increasing growth and yield in plants |
| 04/25/2001 | CN1292827A Nucleic acid transfer vectors, compositions containing same and uses |
| 04/25/2001 | CN1292824A Expression of trehalose biosynthetic genes in plants |
| 04/25/2001 | CN1292823A Stress resistance gene |
| 04/25/2001 | CN1292822A Method for compositions for modifying levels of secondary metabolic compounds in plants |
| 04/25/2001 | CN1292821A Whisker-mediated transformation of plant cell aggregates and plant tissues and regeneration of plants thereof |
| 04/25/2001 | CN1292819A Nucleic acid fragments, recombinant vector containing the same and method for promoting expression of structural gene by using the same |
| 04/25/2001 | CN1292816A Encapsulation of living tissue cells in microsphere |
| 04/25/2001 | CN1292638A Gene mutant animals |
| 04/25/2001 | CN1292416A Molcular method for removing specific tissue of transgenic plant or target gene in organ by utilizing location recombination system |
| 04/25/2001 | CN1292415A Production method of cell containing resveratrol |
| 04/25/2001 | CA2409713A1 Generation of human neural crest cell line and its utilizaton in human transplantation |
| 04/24/2001 | US6222100 Herbicide resistance in plants |
| 04/24/2001 | US6222098 Expression of sucrose phosphorylase in plants |
| 04/24/2001 | US6222094 Mammal whose germ and mammary gland cells contain dna coding for peptide of defined amino acid sequence, signal sequence for secretion, and functional promoter; recombinant production of infant formula |
| 04/24/2001 | US6222027 Molecules expressed in hippocampus |
| 04/24/2001 | US6222026 Gcp |
| 04/24/2001 | US6222022 Amino acid sequences of protein related to glial-derived neurotrophic factor and neurturin; diagnosis and treatment of alzheimer's/parkinson's/huntington's diseases, strokes, brain and spinal chord injuries, amyotrophic lateral sclerosis |
| 04/24/2001 | US6222018 Antibody which binds to transcription factor; for detection in samples; for screening expression libraries |
| 04/24/2001 | US6222014 Amino acid sequence of protein from ribonucleotide diphosphate reductase family; drug screening of bactericides and antibiotics |
| 04/24/2001 | US6222012 Isolated nonapeptides presented by HLA molecules, and uses thereof |
| 04/24/2001 | US6221849 Inhibiting tumor growth |
| 04/24/2001 | US6221840 Intestinal trefoil proteins |
| 04/24/2001 | US6221663 Modulating metabolic or synthetic functionin cell using substrate coated with protein to define a pattern, contacting with cell suspension which binds to protein, contacting with cell suspension which binds to substrate |
| 04/24/2001 | US6221662 Subjecting human neuroblast cell line including epithelial cells to trypsin solution to segregate cells, culturing epithelial cells, treating/culturing isolated cells with tryptamine, generating phenotype including tangles |
| 04/24/2001 | US6221660 Amino acid sequence; recombinant production; drug screening using membrane preparations |
| 04/24/2001 | US6221658 Nucleotide sequence; for decreasing intracellular levels of diacylglycerol and increasing intracellular levels of phosphatidic acid in a eukaryotic cell |
| 04/24/2001 | US6221649 Chimeric bacillus thuringiensis-endotoxins and host cells expressing same |
| 04/24/2001 | US6221633 Insulin derivatives having a rapid onset of action |
| 04/24/2001 | US6221628 Nucleotide sequences coding preferential polypeptide for use in diagnosis and treatment atherosclerosis, ischemia, hypertension, restenosis and arterial inflammation |
| 04/24/2001 | US6221627 cDNA clone HDPB130 that encodes a novel human 7-transmembrane receptor |
| 04/24/2001 | US6221620 Hybridoma that produces immunoglobulin preferential to enzymatic proteins; for diagnosing colon cancer |
| 04/24/2001 | US6221618 Detection of modulators which suppresses cardiovascular disorders; incubate heart muscle cells with inducer of cardiovascular disorders, measure development of hypertrophy |
| 04/24/2001 | US6221616 Detecting modulators of receptor binding protein; incubate cells with modulators and monitoring reduction in binding activity at receptor |
| 04/24/2001 | US6221613 Utilizing competitive binding to detect preferential modulator activity on receptor binding protein; incubate cells with modulators and monitor binding, detect amplification or reduction of binding to receptors |
| 04/24/2001 | US6221593 Diagnosing tumors in cells which express tumor rejection antigen; incubate sample with oligonucleotides, detect hybridization, hybridization is indicative of tumors |
| 04/24/2001 | US6221591 Determination of a genetic risk factor for infection and other diseases, and detection of activated phagocytes |
| 04/24/2001 | US6221580 Anti-idiotypic and its uses in diagnosis and therapy in HIV-related disease |
| 04/24/2001 | US6221576 Process for preparing macrophages, kits, and compositions for the use of this process |
| 04/24/2001 | US6221376 Glial cell line-derived neurotrophic factor |
| 04/24/2001 | US6221351 The enhancement of antitumor immunity and in the treatment of cancer in a tumor-bearing host. |
| 04/24/2001 | US6221349 Adeno-associated vectors for expression of factor VIII by target cells |
| 04/24/2001 | US6221315 Centrifuge, blood, |
| 04/24/2001 | CA2176620C Hepatic growth factor receptor is the met proto-oncogene |
| 04/24/2001 | CA2070659C Antibody preparation |
| 04/21/2001 | CA2321266A1 Anti-dnase-gamma antibody, and production and use thereof |
| 04/19/2001 | WO2001027630A2 Methods to identify compounds that modulate neuronal activity |
| 04/19/2001 | WO2001027324A2 Converting diploidy to haploidy for genetic diagnosis |
| 04/19/2001 | WO2001027304A2 Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna |
| 04/19/2001 | WO2001027303A1 Adeno-associated virus vectors encoding factor viii and methods of using the same |
| 04/19/2001 | WO2001027300A1 Lentiviral vectors for the preparation of immunotherapeutical compositions |
| 04/19/2001 | WO2001027299A1 Vectors and methods for recombinant protein expression |
| 04/19/2001 | WO2001027290A2 Aortic carboxypeptidase-like protein and nucleic acids encoding same |
| 04/19/2001 | WO2001027284A2 Recombinant megalomicin biosynthetic genes and uses thereof |
| 04/19/2001 | WO2001027280A1 Antimicrobial compositions |
| 04/19/2001 | WO2001027268A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 04/19/2001 | WO2001027267A2 Genes differentially expressed in tr1 cells and their use in the manufacture of immunoregulatory compositions |
| 04/19/2001 | WO2001027266A1 Dna segments that are useful for selecting differentiated cell types and the applications thereof |
| 04/19/2001 | WO2001027265A1 Nucleic acid sequences of hyperplasia and tumours of the thyroid |
| 04/19/2001 | WO2001027258A2 High yield protein expression system and methods |
| 04/19/2001 | WO2001027246A1 Novel human potassium channel subunit |
| 04/19/2001 | WO2001027245A2 Generation and characterization of a dendritic cell isolated from human peripheral blood mononuclear cells |
| 04/19/2001 | WO2001027244A1 Body member with adjustable stiffness and frequency |
| 04/19/2001 | WO2001027159A2 Polypeptides for detection and elimination of ca19-9 antigen positive cells |
| 04/19/2001 | WO2001027150A2 Anthozoa derived chromo/fluoroproteins and methods for using the same |
| 04/19/2001 | WO2001027146A2 Chemokine receptor |
| 04/19/2001 | WO2001026680A2 Activation of antigen-specific t cells by virus/antigen-treated dendritic cells |
| 04/19/2001 | WO2001026679A2 T-cells and molecules involved in immune regulation |
| 04/19/2001 | WO2001026678A1 Short segments of dap-kinase |